|
1
|
Linder P and Jankowsky E: From unwinding
to clamping- the DEAD box RNA helicase family. Nat Rev Mol Cell
Biol. 12:505–516. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tanner NK and Linder P: DExD/H box RNA
helicases: From generic motors to specific dissociation functions.
Mol Cell. 8:251–262. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jankowsky E: RNA helicases at work:
Binding and rearranging. Trends Biochem Sci. 36:19–29. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Andreou AZ and Klostermeier D: The
DEAD-box helicase eIF4A: Paradigm or the odd one out. RNA Biol.
10:19–32. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Choe J, Ryu I, Park OH, Park J, Cho H, Yoo
JS, Chi SW, Kim MK, Song HK and Kim YK: eIF4AIII enhances
translation of nuclear cap-binding complex-bound mRNAs by promoting
disruption of secondary structures in 5′UTR. Proc Natl Acad Sci
USA. 111:E4577–E4586. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chan CC, Dostie J, Diem MD, Feng W, Mann
M, Rappsilber J and Dreyfuss G: eIF4A3 is a novel component of the
exon junction complex. RNA. 10:200–209. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Le Hir H and Séraphin B: EJCs at the heart
of translational control. Cell. 133:213–216. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reed R: Coupling transcription, splicing
and mRNA export. Curr Opin Cell Biol. 15:326–331. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reed R and Hurt E: A conserved mRNA export
machinery coupled to pre-mRNA splicing. Cell. 108:523–531. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Le Hir H, Gatfield D, Izaurralde E and
Moore MJ: The exon-exon junction complex provides a binding
platform for factors involved in mRNA export and nonsense-mediated
mRNA decay. EMBO J. 20:4987–4997. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nott A, Le Hir H and Moore MJ: Splicing
enhances translation in mammalian cells: An additional function of
the exon junction complex. Genes Dev. 18:210–222. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Giorgi C and Moore MJ: The nuclear nurture
and cytoplasmic nature of localized mRNPs. Semin Cell Dev Biol.
18:186–193. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Saulière J, Murigneux V, Wang Z, Marquenet
E, Barbosa I, Tonquèze OL, Audic Y, Paillard L, Crollius HR and Le
Hir H: CLIP-seq of eIF4AIII reveals transcriptome-wide mapping of
the human exon junction complex. Nat Struct Mol Biol. 19:1124–1131.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fatscher T, Boehm V and Gehring NH:
Mechanism, factors, and physiological role of nonsense-mediated
mRNA decay. Cell Mol Life Sci. 72:4523–4544. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kashima I, Yamashita A, Izumi N, Kataoka
N, Morishita R, Hoshino S, Ohno M, Dreyfuss G and Ohno S: Binding
of a novel SMG-1-Upf1-eRF1-eRF3 complex (SURF) to the exon junction
complex triggers Upf1 phosphorylation and nonsense-mediated mRNA
decay. Genes Dev. 20:355–367. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bhalla AD, Gudikote JP, Wang J, Chan WK,
Chang YF, Olivas OR and Wilkinson MF: Nonsense codons trigger an
RNA partitioning shift. J Biol Chem. 284:4062–4072. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Barbosa I, Haque N, Fiorini F, Barrandon
C, Tomasetto C, Blanchette M and Le Hir H: Human CWC22 escorts the
helicase eIF4AIII to spliceosomes and promotes exon junction
complex assembly. Nat Struct Mol Biol. 19:983–990. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ryu I, Won YS, Ha H, Kim E, Park YK, Kim
MK, Kwon DH, Choe J, Song HK, Jung H and Kim YK: eIF4A3
phosphorylation by CDKs affects NMD during the cell cycle. Cell
Rep. 26:2126–2139.e9. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu X, Zhao W, Cui Q and Zhou Y:
Computational screening of potential regulators for mRNA-protein
expression level discrepancy. Biochem Biophys Res Commun.
523:196–201. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Michelle L, Cloutier A, Toutant J, Shkreta
L, Thibault P, Durand M, Garneau D, Gendron D, Lapointe E, Couture
S, et al: Proteins associated with the exon junction complex also
control the alternative splicing of apoptotic regulators. Mol Cell
Biol. 32:954–967. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mazloomian A, Araki S, Ohori M, El-Naggar
AM, Yap D, Bashashati A, Nakao S, Sorensen PH, Nakanishi A, Shah S
and Aparicio S: Pharmacological systems analysis defines EIF4A3
functions in cell-cycle and RNA stress granule formation. Commun
Biol. 2:1652019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng X, Huang M, Xing L, Yang R, Wang X,
Jiang R, Zhang L and Chen J: The circRNA circSEPT9 mediated by E2F1
and EIF4A3 facilitates the carcinogenesis and development of
triple-negative breast cancer. Mol Cancer. 19:732020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang S, Leng T, Zhang Q, Zhao Q, Nie X
and Yang L: Sanguinarine inhibits epithelial ovarian cancer
development via regulating long non-coding RNA CASC2-EIF4A3 axis
and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway. Biomed
Pharmacother. 102:302–308. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin Y, Zhang J, Cai J, Liang R, Chen G,
Qin G, Han X, Yuan C, Liu Z, Li Y, et al: Systematic analysis of
gene expression alteration and co-expression network of eukaryotic
initiation factor 4A-3 in cancer. J Cancer. 9:4568–4577. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gatenby PA, Basten A, Tattersall MH and
Fox RM: Autoantibodies in cancer patients given Corynebacterium
parvum/levamisole immunotherapy. Lancet. 1:10821980. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xia Q, Kong XT, Zhang GA, Hou XJ, Qiang H
and Zhong RQ: Proteomics-based identification of DEAD-box protein
48 as a novel autoantigen, a prospective serum marker for
pancreatic cancer. Biochem Biophys Res Commun. 330:526–532. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tian M, Cheng H, Wang Z, Su N, Liu Z, Sun
C, Zhen B, Hong X, Xue Y and Xu P: Phosphoproteomic analysis of the
highly-metastatic hepatocellular carcinoma cell line, MHCC97-H. Int
J Mol Sci. 16:4209–4225. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin Y, Liang R, Mao Y, Ye J, Mai R, Gao X,
Liu Z, Wainwright T, Li Q, Luo M, et al: Comprehensive analysis of
biological networks and the eukaryotic initiation factor 4A-3 gene
as pivotal in hepatocellular carcinoma. J Cell Biochem.
121:4094–4107. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang J, Zhou YJ, Yu ZH, Chen AX, Yu Y,
Wang X and Cao XC: Identification of core genes and clinical roles
in pregnancy-associated breast cancer based on integrated analysis
of different microarray profile datasets. Biosci Rep.
39:BSR201900192019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang R, Zhang S, Chen X, Li N, Li J, Jia
R, Pan Y and Liang H: EIF4A3-induced circular RNA MMP9 (circMMP9)
acts as a sponge of miR-124 and promotes glioblastoma multiforme
cell tumorigenesis. Mol Cancer. 17:1662018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun D, Wang G, Xiao C and Xin Y:
Hsa_circ_001988 attenuates GC progression in vitro and in vivo via
sponging miR-197-3p. J Cell Physiol. 236:612–624. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Feng L, Li J, Li F, Li H, Bei S, Zhang X
and Yang Z: Long noncoding RNA VCAN-AS1 contributes to the
progression of gastric cancer via regulating p53 expression. J Cell
Physiol. 235:4388–4398. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Afzali F and Salimi M: Unearthing
regulatory axes of breast cancer circRNAs networks to find novel
targets and fathom pivotal mechanisms. Interdiscip Sci. 11:711–722.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun HD, Xu ZP, Sun ZQ, Zhu B, Wang Q, Zhou
J, Jin H, Zhao A, Tang WW and Cao XF: Down-regulation of circPVRL3
promotes the proliferation and migration of gastric cancer cells.
Sci Rep. 8:101112018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tang W, Wang D, Shao L, Liu X, Zheng J,
Xue Y, Ruan X, Yang C, Liu L, Ma J, et al: LINC00680 and TTN-AS1
stabilized by EIF4A3 promoted malignant biological behaviors of
glioblastoma cells. Mol Ther Nucleic Acids. 19:905–921. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang H, Yang W, Dai W, Ma Y and Zhang G:
LINC00667 promotes the proliferation, migration, and pathological
angiogenesis in non-small cell lung cancer through stabilizing
VEGFA by EIF4A3. Cell Biol Int. 44:1671–1680. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li Q, Lei C, Lu C, Wang J, Gao M and Gao
W: LINC01232 exerts oncogenic activities in pancreatic
adenocarcinoma via regulation of TM9SF2. Cell Death Dis.
10:6982019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tsumuraya T, Ishikawa C, Machijima Y,
Nakachi S, Senba M, Tanaka J and Mori N: Effects of hippuristanol,
an inhibitor of eIF4A, on adult T-cell leukemia. Biochem Pharmacol.
81:713–722. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Popp MW and Maquat LE: Attenuation of
nonsense-mediated mRNA decay facilitates the response to
chemotherapeutics. Nat Commun. 6:66322015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pastor F, Kolonias D, Giangrande PH and
Gilboa E: Induction of tumour immunity by targeted inhibition of
nonsense-mediated mRNA decay. Nature. 465:227–230. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shen L and Pelletier J: Selective
targeting of the DEAD-box RNA helicase eukaryotic initiation factor
(eIF) 4A by natural products. Nat Prod Rep. 37:609–616. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lindqvist L, Oberer M, Reibarkh M, Cencic
R, Bordeleau ME, Vogt E, Marintchev A, Tanaka J, Fagotto F, Altmann
M, et al: Selective pharmacological targeting of a DEAD box RNA
helicase. PLoS One. 3:e15832008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Low WK, Dang Y, Schneider-Poetsch T, Shi
Z, Choi NS, Merrick WC, Romo D and Liu JO: Inhibition of eukaryotic
translation initiation by the marine natural product pateamine A.
Mol Cell. 20:709–722. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Dang Y, Low WK, Xu J, Gehring NH, Dietz
HC, Romo D and Liu JO: Inhibition of nonsense-mediated mRNA decay
by the natural product pateamine A through eukaryotic initiation
factor 4AIII. J Biol Chem. 284:23613–23621. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bordeleau ME, Robert F, Gerard B,
Lindqvist L, Chen SMH, Wendel HG, Brem B, Greger H, Lowe SW, Porco
JA Jr and Pelletier J: Therapeutic suppression of translation
initiation modulates chemosensitivity in a mouse lymphoma model. J
Clin Invest. 118:2651–2660. 2008.PubMed/NCBI
|
|
46
|
Ito M, Tanaka T, Cary DR,
Iwatani-Yoshihara M, Kamada Y, Kawamoto T, Aparicio S, Nakanishi A
and Imaeda Y: Discovery of novel 1,4-diacylpiperazines as selective
and cell-active eIF4A3 inhibitors. J Med Chem. 60:3335–3351. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Iwatani-Yoshihara M, Ito M, Ishibashi Y,
Oki H, Tanaka T, Morishita D, Ito T, Kimura H, Imaeda Y, Aparicio
S, et al: Discovery and characterization of a eukaryotic initiation
factor 4A-3-selective inhibitor that suppresses nonsense-mediated
mRNA decay. ACS Chem Biol. 12:1760–1768. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ito M, Iwatani M, Kamada Y, Sogabe S,
Nakao S, Tanaka T, Kawamoto T, Aparicio S, Nakanishi A and Imaeda
Y: Discovery of selective ATP-competitive eIF4A3 inhibitors. Bioorg
Med Chem. 25:2200–2209. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mizojiri R, Nakata D, Satoh Y, Morishita
D, Shibata S, Iwatani-Yoshihara M, Kosugi Y, Kosaka M, Takeda J,
Sasaki S, et al: Discovery of novel
5-(Piperazine-1-carbonyl)pyridin-2(1H)-one derivatives as orally
eIF4A3-selective inhibitors. ACS Med Chem Lett. 8:1077–1082. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Haremaki T, Sridharan J, Dvora S and
Weinstein DC: Regulation of vertebrate embryogenesis by the exon
junction complex core component Eif4a3. Dev Dyn. 239:1977–1987.
2010. View Article : Google Scholar : PubMed/NCBI
|
